Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninjin-yoeito for perioperative nutritional management in oral squamous cell carcinoma with malnutrition
jRCTs071230055Completed
- Sponsor
- Kracie Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ninjinyoeito in Oral Mucosal Carcinoma and Malnutrition, sponsored by Kracie Pharmaceutical. Primary endpoint: Change in postoperative prognostic nutritional index (PNI). Started Nov 2023; status: completed.
02
Drugs
ninjinyoeito
03
Conditions
Oral Mucosal CarcinomaMalnutrition
Beyond the preview
Go deeper on jRCTs071230055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071230055.